1,577 Shares in Chemed Co. (NYSE:CHE) Acquired by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd purchased a new position in Chemed Co. (NYSE:CHEFree Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 1,577 shares of the company’s stock, valued at approximately $835,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. UMB Bank n.a. increased its stake in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after acquiring an additional 39 shares in the last quarter. Trust Co. of Vermont bought a new stake in shares of Chemed in the 4th quarter valued at $34,000. Allworth Financial LP increased its stake in shares of Chemed by 2,057.1% in the 4th quarter. Allworth Financial LP now owns 151 shares of the company’s stock valued at $83,000 after acquiring an additional 144 shares in the last quarter. Farther Finance Advisors LLC increased its stake in Chemed by 2,314.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock valued at $203,000 after purchasing an additional 324 shares in the last quarter. Finally, KBC Group NV increased its stake in Chemed by 11.5% during the 3rd quarter. KBC Group NV now owns 378 shares of the company’s stock valued at $227,000 after purchasing an additional 39 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analyst Ratings Changes

CHE has been the subject of several recent analyst reports. StockNews.com lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday. Royal Bank of Canada reduced their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th.

Check Out Our Latest Research Report on CHE

Insider Buying and Selling

In other Chemed news, VP Brian C. Judkins acquired 145 shares of the company’s stock in a transaction on Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, with a total value of $75,327.50. Following the completion of the acquisition, the vice president now directly owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.32% of the stock is owned by insiders.

Chemed Stock Performance

Shares of NYSE:CHE opened at $586.11 on Friday. The company’s 50-day moving average is $543.86 and its 200 day moving average is $563.11. The company has a market capitalization of $8.82 billion, a P/E ratio of 29.62, a price-to-earnings-growth ratio of 2.15 and a beta of 0.48. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $654.62.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date is Monday, February 24th. Chemed’s dividend payout ratio (DPR) is currently 10.11%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.